PROCEPT BioRobotics (PRCT) Asset Writedowns and Impairment (2020 - 2026)
PROCEPT BioRobotics' (PRCT) quarterly Asset Writedowns and Impairment came in at $195000.0 in Q1 2026, down 40.91% year-on-year from $330000.0 in Q1 2025, and up 156.2% on a QoQ basis from -$347000.0 in Q4 2025.
PROCEPT BioRobotics (PRCT) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends
PROCEPT BioRobotics (PRCT) has 7 years of Asset Writedowns and Impairment data on file, last reported at $195000.0 in Q1 2026.
- On a quarterly basis, Asset Writedowns and Impairment fell 40.91% year-over-year to $195000.0 in Q1 2026; TTM through Mar 2026 was $84000.0, a 96.2% decrease from a year earlier, with the FY2025 full-year figure at $219000.0, down 88.36% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at $195000.0, up from -$347000.0 in the prior quarter.
- Over the last five years, Asset Writedowns and Impairment for PRCT reached as high as $905000.0 in Q2 2024 and fell as low as -$995000.0 in Q4 2023.
- Historically, Asset Writedowns and Impairment has averaged $168357.1 across 5 years, with a median of $190500.0 in 2023.
- On a YoY basis, Asset Writedowns and Impairment climbed as much as 567.82% in 2023 and fell as far as 3880.0% in 2023.
- Year by year, Asset Writedowns and Impairment stood at -$25000.0 in 2022, then slumped by 3880.0% to -$995000.0 in 2023, then soared by 160.3% to $600000.0 in 2024, then plunged by 157.83% to -$347000.0 in 2025, then jumped by 156.2% to $195000.0 in 2026.
- Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $195000.0 in Q1 2026, -$347000.0 in Q4 2025, and $76000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.35 Bn | 175.06 Bn | 6.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn |
| 3 | Medtronic | 107.93 Bn | 98.71 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.82 Bn | 66.37 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.03 Bn | 44.36 Bn | 1.29 Bn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.90 Bn | 25.62 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 23.96 Bn | 20.83 Bn | 2.07 Bn |
| 10 | PROCEPT BioRobotics | 1.00 Bn | 758.56 Mn | 53.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 195,000.00 |
| Mar 31, 2026 | 195,000.00 |
| Dec 31, 2025 | -347,000.00 |
| Dec 31, 2025 | -347,000.00 |
| Sep 30, 2025 | 76,000.00 |
| Sep 30, 2025 | 76,000.00 |
| Jun 30, 2025 | 160,000.00 |
| Jun 30, 2025 | 160,000.00 |
| Mar 31, 2025 | 330,000.00 |
| Mar 31, 2025 | 330,000.00 |
| Dec 31, 2024 | 600,000.00 |
| Dec 31, 2024 | 600,000.00 |
| Sep 30, 2024 | 376,000.00 |
| Sep 30, 2024 | 376,000.00 |
| Jun 30, 2024 | 905,000.00 |
| Jun 30, 2024 | 905,000.00 |
| Dec 31, 2023 | -995,000.00 |
| Dec 31, 2023 | -995,000.00 |
| Sep 30, 2023 | 581,000.00 |
| Sep 30, 2023 | 581,000.00 |